SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Precigen, Inc (f/k/a Intrexon Corporation) - PGENPRNewsWire • 10/08/20
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Precigen, Inc. (PGEN), f/k/a Intrexon Corp. (XON) Investors with Losses to Contact Its Attorneys, Securities Fraud Action Filed, Important Deadline EstablishedNewsfile Corp • 10/08/20
PGEN INVESTOR ALERT: Bernstein Liebhard Announces that a Securities Class Action Lawsuit Has Been Filed Against Precigen Inc., f/k/a Intrexon CorporationBusiness Wire • 10/07/20
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Precigen, Inc. f/k/a Intrexon Corporation Investors of Important Deadline in Securities Class Action First Filed by the Firm – PGEN, XONBusiness Wire • 10/07/20
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Precigen, Inc. f/k/a Intrexon Corporation (PGEN, XON) InvestorsBusiness Wire • 10/06/20
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Precigen, Inc. (PGEN), f/k/a Intrexon Corp. (XON) Investors with Losses to Contact Its AttorneysPRNewsWire • 10/06/20
Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Precigen, Inc. f/k/a Intrexon Corporation (PGEN, XON) InvestorsBusiness Wire • 10/06/20
Rosen, A Leading Law Firm, First Files Securities Class Action Lawsuit Against Precigen, Inc. f/k/a Intrexon Corporation - PGEN, XONNewsfile Corp • 10/06/20
PGEN LOSSES ALERT: Bernstein Liebhard is Investigating Precigen Inc., f/k/a Intrexon Corporation For Violations of the Securities LawsBusiness Wire • 10/06/20
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Precigen, Inc. f/k/a Intrexon Corporation – PGEN, XONBusiness Wire • 10/05/20
The Law Offices of Frank R. Cruz Continues Its Investigation of Precigen, Inc. (PGEN) on Behalf of InvestorsBusiness Wire • 10/05/20
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Precigen, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 10/05/20
PGEN INVESTIGATION ALERT: Bernstein Liebhard Is Investigating Precigen Inc., f/k/a Intrexon Corporation for Violations of the Securities LawsBusiness Wire • 10/05/20
Rosen, Global Investor Counsel, Announces Investigation of Securities Claims Against Precigen, Inc. f/k/a Intrexon Corporation - PGEN, XONNewsfile Corp • 10/03/20
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Precigen, Inc. (PGEN), f/k/a Intrexon Corp. (XON) Investors with Losses to Contact Its Attorneys, SEC Finds Company Violated Securities LawsPRNewsWire • 10/03/20
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Precigen, Inc. f/k/a Intrexon Corporation (PGEN, XON) on Behalf of InvestorsBusiness Wire • 10/02/20
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Precigen, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 10/02/20
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Precigen, Inc. f/k/a Intrexon Corporation (PGEN, XON) on Behalf of InvestorsBusiness Wire • 10/02/20
The Law Offices of Frank R. Cruz Announces Investigation of Precigen, Inc. (PGEN) on Behalf of InvestorsBusiness Wire • 10/02/20
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Precigen, Inc. f/k/a Intrexon Corporation – PGEN, XONBusiness Wire • 10/02/20
Precigen Announces First Patient Dosed in Phase I/II Study of First-in-Class PRGN-2009 AdenoVerse™ Immunotherapy to Treat HPV-associated CancersPRNewsWire • 08/17/20
Precigen, Inc. (PGEN) CEO Helen Sabzevari on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/11/20
Precigen ActoBio Announces Positive Topline Results from Phase 1b Study of AG019 ActoBiotics™, A Novel Therapy Designed to Address the Underlying Cause of Type 1 DiabetesPRNewsWire • 08/10/20
